Cargando…

Antibiotic Use in China’s Public Healthcare Institutions During the COVID-19 Pandemic: An Analysis of Nationwide Procurement Data, 2018–2020

Background: The overuse of antibiotics is a serious public health problem and a major challenge in China, and China lacks up-to-date evidence on the nationwide antibiotic use in different healthcare settings. The changes of China’s antibiotic use under the COVID-19 pandemic are still unknown. Object...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Ying, Geng, Xin, Liu, Xiaojun, Wen, Xiaotong, Wu, Ruonan, Cui, Dan, Mao, Zongfu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882946/ https://www.ncbi.nlm.nih.gov/pubmed/35237164 http://dx.doi.org/10.3389/fphar.2022.813213

Ejemplares similares

The change of drug utilization in China’s public healthcare institutions under the “4 + 7” centralized drug procurement policy: Evidence from a natural experiment in China
por: Lu, Jiancheng, et al.
Publicado: (2022)

A quasi-experimental study of the volume-based procurement (VBP) effect on antiviral medications of hepatitis B virus in China
por: Wen, Xiaotong, et al.
Publicado: (2023)

Changing Characteristics of Pharmaceutical Prices in China Under Centralized Procurement Policy: A Multi-Intervention Interrupted Time Series
por: Long, Hongfei, et al.
Publicado: (2022)

Problems and challenges encountered by Chinese medical institutions in implementing the national centralized drug procurement
por: Zhang, Wen, et al.
Publicado: (2023)

Antibiotic Expenditure by Public Healthcare Institutions in Shandong Province in China, 2012–2016
por: Yin, Jia, et al.
Publicado: (2018)

The impacts of Chinese drug volume-based procurement policy on the use of policy-related antibiotic drugs in Shenzhen, 2018–2019: an interrupted time-series analysis
por: Yang, Ying, et al.
Publicado: (2021)

Impact of the Expert Consensus on Carbapenem Consumption Trends and Patterns in Public Healthcare Institutes: An Interrupted Time Series Analysis, 2017–2020
por: Ye, Dan, et al.
Publicado: (2022)

Analysis of Antibiotic Use Patterns and Trends Based on Procurement Data of Healthcare Institutions in Shaanxi Province, Western China, 2015–2018
por: Xu, Sen, et al.
Publicado: (2020)

The impacts of the “4+7” pilot policy on the volume, expenditures, and daily cost of Serotonin-Specific Reuptake Inhibitors (SSRIs) antidepressants: A quasi-experimental study
por: Wen, Xiaotong, et al.
Publicado: (2022)

Impact of ‘4+7’ volume-based drug procurement on the use of policy-related original and generic drugs: a natural experimental study in China
por: Wang, Jing, et al.
Publicado: (2022)

Impact of National Volume-Based Procurement on the Procurement Volumes and Spending for Antiviral Medications of Hepatitis B Virus
por: Yuan, Jing, et al.
Publicado: (2022)

Influence of Chinese National Centralized Drug Procurement on the price of policy-related drugs: an interrupted time series analysis
por: Wang, Ni, et al.
Publicado: (2021)

The impact of key monitoring policy on the usage of policy-related drugs in Hubei Province, China
por: Wen, Xiaotong, et al.
Publicado: (2023)

Sustainable public procurement in a Brazilian higher education institution
por: Mendonça, Renata C. A., et al.
Publicado: (2021)

Report on procurement activity in 2020
Publicado: (2021)

Pharmaceutical procurement among public sector procurers in CARICOM
por: Preston, Charles, et al.
Publicado: (2021)

Healthcare professionals’ knowledge, attitude and practice towards National Centralized Drug Procurement policy in central China: A cross-sectional study
por: Huang, Anqi, et al.
Publicado: (2022)

The Effects of a New Public Medicine Procurement Policy on Medicine Price in Shaanxi Province, Western China: An Interrupted Time Series Analysis
por: Hu, Shuchen, et al.
Publicado: (2019)

An Architect's Guide to Public Procurement
por: Garvey, Fin
Publicado: (2019)

Does China improve social welfare after implementing the national volume-based procurement?
por: Wang, Huan, et al.
Publicado: (2023)

Antibiotics (Macrolides and Lincosamides) Consumption Trends and Patterns in China’s Healthcare Institutes. Based on a 3 Year Procurement Records, 2015–2017
por: Liu, Wenchen, et al.
Publicado: (2020)

FOPPA: an open database of French public procurement award notices from 2010–2020
por: Potin, Lucas, et al.
Publicado: (2023)

Public food procurement as a tool for more sustainable and high quality food offer in public institutions
por: Gabrijelčič, M, et al.
Publicado: (2023)

Knowledge, Attitudes and Practice of Healthcare Providers, Healthcare Regulatory Practitioners and Patients Toward Biosimilars in China: Insights From a Nationwide Survey
por: Hu, Yang, et al.
Publicado: (2022)

Government Policy for the Procurement of Food from Local Family Farming in Brazilian Public Institutions
por: Soares, Panmela, et al.
Publicado: (2021)

The Impacts of National Centralized Drug Procurement Policy on Drug Utilization and Drug Expenditures: The Case of Shenzhen, China
por: Chen, Lei, et al.
Publicado: (2020)

Scaling behavior of public procurement activity
por: Curado, António, et al.
Publicado: (2021)

Procurement of medicines to treat cancer, 2015–2020, China
por: Pan, Mengyuan, et al.
Publicado: (2022)

Secular trend analysis of antibiotic utilisation in China’s hospitals 2011–2018, a retrospective analysis of procurement data
por: Wushouer, Haishaerjiang, et al.
Publicado: (2020)

Dispensing of psychotropic drugs in the Brazilian capital city before and during the COVID-19 pandemic (2018–2020)
por: Escalante Saavedra, Pamela Alejandra, et al.
Publicado: (2022)

Antibiotic use and irrational antibiotic prescriptions in 66 primary healthcare institutions in Beijing City, China, 2015–2018
por: Taxifulati, Yumiti, et al.
Publicado: (2021)

Experience of public procurement of Open Compute servers
por: Bärring, Olof, et al.
Publicado: (2015)

Corruption in healthcare: global perspectives and the recent escalation of violence in Ecuador's public medicine procurement system
por: Ortiz-Prado, Esteban, et al.
Publicado: (2023)

A European arena for joint innovation in healthcare: The Platform for Innovation of Procurement and Procurement of Innovation (PiPPi)
por: Andrews, Margaret R., et al.
Publicado: (2023)

Analysis of Green Public Procurement of Works by Spanish Public Universities
por: Fuentes-Bargues, Jose Luis, et al.
Publicado: (2018)

Traceability of Pediatric Antibiotic Purchasing Pathways in Italy: A Nationwide Real-World Drug Utilization Analysis
por: Sultana, Janet, et al.
Publicado: (2020)

Report on Procurement during the Period 1 January to 31 December 2018
Publicado: (2019)

National drug utilization trend of analgesics in China: an analysis of procurement data at 793 public hospitals from 2013 to 2018
por: Shi, Honghao, et al.
Publicado: (2021)

Prevalence of Antibiotic Purchase Online and Associated Factors Among Chinese Residents: A Nationwide Community Survey of 2019
por: Sun, Na, et al.
Publicado: (2021)

The impact of “4 + 7” volume-based drug procurement on the volume, expenditures, and daily costs of antihypertensive drugs in Shenzhen, China: an interrupted time series analysis
por: Yang, Ying, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_71eqsa8loqsptc3go9jh9c0bo9